Manisha Bahl

8PUBLICATIONS
60CO-AUTHORS
Molecular targetsModels of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 10, 2026
EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.

|Jun 19, 2026
Survey of the Senologic International Society (SIS) on the Use of Preoperative Breast MRI in Early-Stage Breast Cancer: A Global Perspective on Current Practice.

|Jun 19, 2026
Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study.

|Mar 13, 2025
Male Breast Cancer in Portugal: A Descriptive Analysis of a 20-Year Cohort.

Maria Alexandra Montenegro, Tiago Dias Domingues, Teresa Mota Garcia

|Aug 03, 2023
Symptom Clusters in Patients With Advanced Cancer: A Prospective Longitudinal Cohort Study to Examine Their Stability and Prognostic Significance.

Diana Simão, Pedro C Barata, Marta Alves

|Mar 11, 2023
Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer.

Diana C Simão, Kevin K Zarrabi, José L Mendes

Pageof 2

Frequent Collaborators

4 joint publications

Vaidotas Cesna

3 joint publications

Marianna Telesca

3 joint publications

Rita Quaresma Ferreira

3 joint publications

Diogo Alpuim Costa